08:00 , Feb 1, 2016 |  BC Week In Review  |  Clinical News

AK001: Phase I ongoing

Allakos completed dosing of 34 healthy volunteers and patients in a double-blind, placebo-controlled, U.S. Phase I trial evaluating single ascending doses of parenteral AK001. Allakos Inc. , San Carlos, Calif.   Product: AK001   Business:...
07:00 , May 14, 2015 |  BC Innovations  |  Targets & Mechanisms

Sense and sensibility

While bronchodilators and steroids have long been the mainstays of asthma treatment, the dogma has been that the two classes of drugs address distinct processes, airway constriction and inflammation. That hypothesis might be turned on...
08:00 , Jan 16, 2001 |  BioCentury  |  Tools & Techniques

Philips juices up microfluidics

Philips Research, a division of Koninklijke Philips Electronics N.V. (PHG, Amsterdam, the Netherlands), has developed a microfluidics technology that potentially could be used to improve microfluidic lab-on-a-chip separation technologies, as well as improving the dispensing...